Sleep, neuroscience and oncology drugs
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 38 | Added +5% | 160 | $30,248 | 0.0% |
| Howard Marks / Oaktree | 69 | Trimmed -59% | 4,383,000 | $6,217,284 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.